Clovis Oncology
- Pharmaceutical Preparations
- Boulder, Colorado
Compensation history
Top executives at Clovis Oncology received an average of $2M per person in annual compensation from 2010 to 2021.
Average pay of disclosed executives at Clovis Oncology
By year
- 2021
PM$3MPatrick J. MahaffyPresident and Chief Executive OfficerLR$1MLindsey RolfeEVP of Clinical Development and Pharmacovigilance and Chief Medical OfficerGI$1MGillian C. Ivers-ReadEVP and Chief Regulatory OfficerPG$1MPaul E. GrossEVP and General CounselDM$1MDaniel W. MuehlEVP and Chief Financial Officer- 2020
PM$3MPatrick J. MahaffyPresident and Chief Executive OfficerLR$1MLindsey RolfeEVP of Clinical Development and Pharmacovigilance and Chief Medical OfficerGI$1MGillian C. Ivers-ReadEVP and Chief Regulatory OfficerPG$1MPaul E. GrossEVP and General CounselDM$1MDaniel W. MuehlEVP and Chief Financial Officer- 2019
PM$7MPatrick J. MahaffyPresident and Chief Executive OfficerPG$4MPaul E. GrossEVP and General CounselDM$4MDaniel W. MuehlEVP and Chief Financial OfficerLR$3MLindsey RolfeEVP of Clinical and Development and Pharmacovigilance and Chief Medical OfficerGI$3MGillian C. Ivers-ReadEVP and Chief Regulatory Officer
Executives
We found nine executives who work or worked at Clovis Oncology.
Patrick Mahaffy
Clovis Oncology
Chief Executive Officer
Daniel Muehl
Clovis Oncology
Chief Financial Officer
Gillian Ivers-Read
Clovis Oncology
EVP and Chief Regulatory Officer
Lindsey Rolfe
Clovis Oncology
Chief Medical Officer
Paul Gross
Clovis Oncology
General Counsel
C Hooks
Clovis Oncology
Former Senior VP and Chief Commercial Officer
Erle Mast
Clovis Oncology
Chief Financial Officer
Steven Hoerter
Clovis Oncology
EVP and Chief Commercial Officer
News
Clovis Oncology CEO Patrick Mahaffy's 2021 pay slips 18% to $2.6M
April 27, 2022
Clovis Oncology CEO Patrick Mahaffy's 2020 pay falls 53% to $3.2M
April 28, 2021
Clovis Oncology CEO Patrick Mahaffy's 2019 pay rises 10% to $6.9M
April 24, 2020
Clovis Oncology CEO Patrick Mahaffy's 2018 pay falls 28% to $6.3M
April 26, 2019
About Clovis Oncology
- Industry classifications
- DivisionManufacturing
- Major groupChemicals And Allied Products
- Industry groupDrugs
- IndustryPharmaceutical Preparations
- Address5500 Flatiron Parkway, Suite 100, Boulder, Colorado 80301
- Phone(303) 625-5000
- Fiscal year endDecember 31
Source: SEC filings on April 27, 2022, April 28, 2021, April 24, 2020, April 26, 2019, April 27, 2018, April 26, 2017, April 27, 2016, April 30, 2015, April 30, 2014, and April 29, 2013.